← Back to guidelines
Cardiology305 papers

White matter disease

Last edited: 4/15/2026

Overview

White matter disease encompasses various conditions affecting the white matter of the brain, including white matter hyperintensities (WMH) and other demyelinating or degenerative disorders distinct from multiple sclerosis, such as adrenoleukodystrophy and neuromyelitis optica 12.

Diagnosis

  • Imaging: MRI is essential for identifying white matter hyperintensities and other structural abnormalities 1.
  • Differential Diagnosis: Distinguish from multiple sclerosis, neuromyelitis optica, and acute disseminated encephalomyelitis through clinical presentation and specific biomarkers 2.
  • Genetic Testing: Consider for suspected adrenoleukodystrophy to identify specific gene mutations 2.
  • Management

  • Supportive Care: Focus on managing symptoms and comorbidities, tailored to the underlying condition 1.
  • Specific Treatments:
  • - Adrenoleukodystrophy: Hematopoietic stem cell transplantation may be considered in certain cases 2. - Neuromyelitis Optica: Immunosuppressive therapies such as rituximab or plasma exchange for severe cases 2.

    Special Populations

  • Pediatrics: Early diagnosis and intervention are crucial for conditions like adrenoleukodystrophy 2.
  • Elderly: Focus on risk factor modification (e.g., hypertension, hyperlipidemia) to potentially slow progression of WMH 1.
  • Key Recommendations

  • Utilize MRI for accurate diagnosis of white matter abnormalities and to differentiate from other demyelinating diseases (Evidence: Moderate) 12.
  • Consider genetic testing for adrenoleukodystrophy in patients with clinical suspicion to guide specific management strategies (Evidence: Moderate) 2.
  • Tailor supportive care and specific treatments based on the underlying white matter disease, with hematopoietic stem cell transplantation being a potential option for adrenoleukodystrophy (Evidence: Weak) 2.
  • References

    1 Park B. You're the Flight Surgeon: white matter hyperintensities. Aerospace medicine and human performance 2015. link 2 O'Riordan JI. Central nervous system white matter diseases other than multiple sclerosis. Current opinion in neurology 1997. link 3 Hampl JS, Betts NM. Comparisons of dietary intake and sources of fat in low- and high-fat diets of 18- to 24-year-olds. Journal of the American Dietetic Association 1995. link00247-2)

    Original source

    1. [1]
      You're the Flight Surgeon: white matter hyperintensities.Park B Aerospace medicine and human performance (2015)
    2. [2]
      Central nervous system white matter diseases other than multiple sclerosis.O'Riordan JI Current opinion in neurology (1997)
    3. [3]
      Comparisons of dietary intake and sources of fat in low- and high-fat diets of 18- to 24-year-olds.Hampl JS, Betts NM Journal of the American Dietetic Association (1995)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG